NU-MED PLUS, INC. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
NU-MED PLUS, INC. (NUMD) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $4.75 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-08-14
- NU-MED PLUS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-03-31 was $3.62K.
- NU-MED PLUS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was $0.00.
- NU-MED PLUS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-03-31 was -$20.17K.
- NU-MED PLUS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2022-03-31 was -$9.14K.
- NU-MED PLUS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was -$1.71K.
- NU-MED PLUS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was -$4.43K.
- NU-MED PLUS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was -$66.39K, a 207.91% decline from fiscal 2022.
- NU-MED PLUS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was $61.52K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.75K 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | $3.62K 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | -$1.71K 10-K · filed 2026-04-15 | |||
| 2025-06-30 | -$1.51K 10-Q · filed 2026-08-14 | |||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-14 | |||
| 2024-12-31 | -$4.43K 10-K · filed 2026-04-15 | |||
| 2024-09-30 | -$2.77K 10-Q · filed 2024-11-14 | |||
| 2023-12-31 | -$66.39K 10-K · filed 2025-03-31 | |||
| 2023-09-30 | -$62.11K 10-Q · filed 2024-11-14 | |||
| 2023-06-30 | -$43.24K 10-Q · filed 2023-08-11 | |||
| 2023-03-31 | -$20.17K 10-Q · filed 2023-05-10 | |||
| 2022-12-31 | $61.52K 10-K · filed 2024-03-26 | |||
| 2022-09-30 | -$11.05K 10-Q · filed 2023-11-01 | |||
| 2022-06-30 | -$11.68K 10-Q · filed 2023-08-11 | |||
| 2022-03-31 | -$9.14K 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | -$176.83K 10-K/A · filed 2023-04-03 | |||
| 2021-03-31 | -$49.24K 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | $181.43K 10-K/A · filed 2022-04-11 |